LONDON (AP) — Alexander Zverev was dealing with more than just defending champion Jannik Sinner on Sunday in the Wimbledon ...

Share on Pinterest Could GLP-1s hold the key to protecting people with diabetes against long COVID? Image credit: Jon Challicom/ Getty Images Some people develop long COVID after a SARS-CoV-2 ...

The advent of an immunotherapy to delay type 1 diabetes and more potential treatments in the pipeline have shifted the way ...

Type 1 diabetes management involves monitoring blood sugar, diet, activity, and insulin treatment. Support from parents and ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and the active ingredient in the medications Wegovy and Ozempic. Both Wegovy and Ozempic are available in injectable forms you ...

Insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to ...

What is type 2 diabetes? Type 2 diabetes (T2DM) is a condition that causes high blood sugar (glucose) levels. Insulin is a ...

A novel plasmid-based immunotherapy was safe and well tolerated among adults with type 1 diabetes autoantibodies, according ...

Almost 6 million people in the UK are living with diabetes, with many unaware they have the condition ...

LONDON—Alexander Zverev was dealing with more than just defending champion Jannik Sinner on Sunday in the Wimbledon final.

New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...